ROCCO M CAMBARERI
Allopathic & Osteopathic Physicians|Family Medicine SYRACUSE, NY NPI 1962815944
Browse related groups: Allopathic & Osteopathic Physicians|Family Medicine NY ABBVIE INC. All categories
General Payments — all program years on this page
$8,435.37
- Category: General Payments
- Program years: PY2018–2024
- Record count: 549
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,649.50 across 88 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,649.50 | 88 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $289.36 | 20 |
| Novo Nordisk AS | $231.49 | 18 |
| Abbott Laboratories | $223.77 | 12 |
| Acerta Pharma LLC | $135.90 | 3 |
| ITI, Inc. | $109.60 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $103.43 | 4 |
| Gilead Sciences, Inc. | $64.45 | 3 |
| GlaxoSmithKline, LLC. | $53.00 | 3 |
| Amneal Pharmaceuticals LLC | $52.96 | 2 |
| Phathom Pharmaceuticals, Inc. | $42.26 | 3 |
| Otsuka America Pharmaceutical, Inc. | $40.56 | 2 |
| Merck Sharp & Dohme Corporation | $37.66 | 2 |
| Sumitomo Pharma America, Inc. | $34.00 | 2 |
| Inspire Medical Systems, Inc. | $32.52 | 1 |
| Amgen Inc. | $31.83 | 2 |
| PFIZER INC. | $28.94 | 2 |
| Bayer HealthCare Pharmaceuticals Inc. | $26.87 | 2 |
| Kyowa Kirin, Inc. | $26.21 | 1 |
| Lundbeck LLC | $20.33 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $18.33 | 1 |
| Mylan Specialty L.P. | $16.63 | 1 |
| Esperion Therapeutics, Inc. | $15.21 | 1 |
| Kowa Pharmaceuticals America, Inc. | $14.19 | 1 |
By program year
Records — PY2024 (88)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.